Predicting which HIV patients will respond better to future therapeutic vaccine
A new study suggests that HIV patients with a higher level of a particular biomarker, or a measurable indicator found in the blood, may respond more favourably to an experimental immune activating vaccine.
Jul 18, 2014
0
0